Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena V Dementyeva

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|January 21, 2009
X-chromosome upregulation and inactivation: two sides of the dosage compensation mechanism in mammalsElena V Dementyeva, Alexander I Shevchenko, Suren M Zakian
International Journal of Molecular Sciences|August 29, 2024
Studying Pathogenetic Contribution of a Variant of Unknown Significance, p.M659I (c.1977G > A) in MYH7, to the Development of Hypertrophic Cardiomyopathy Using CRISPR/Cas9-Engineered Isogenic Induced Pluripotent Stem CellsSophia V Pavlova, Angelina E Shulgina, Suren M Zakian, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|July 25, 2009
Mosaic heterochromatin of the inactive X chromosome in vole Microtus rossiaemeridionalisAlexander I Shevchenko, Sophia V Pavlova, Elena V Dementyeva, et al.
The International Journal of Developmental Biology|May 7, 2019
Diverse developmental strategies of X chromosome dosage compensation in eutherian mammalsAlexander I Shevchenko, Elena V Dementyeva, Irina S Zakharova, et al.
International Journal of Molecular Sciences|December 17, 2024
Generation of Isogenic iPSC Lines for Studying the Effect of the p.N515del (c.1543_1545delAAC) Variant on MYBPC3 Function and Hypertrophic Cardiomyopathy PathogenesisSophia V Pavlova, Angelina E Shulgina, Julia M Minina, et al.
Cardiology Research and Practice|April 26, 2016
Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease ModelingDaniel R Bayzigitov, Sergey P Medvedev, Elena V Dementyeva, et al.
Plos One|February 8, 2014
Dynamics of the two heterochromatin types during imprinted X chromosome inactivation in vole Microtus levisEvgeniya A Vaskova, Elena V Dementyeva, Alexander I Shevchenko, et al.
Chromosoma|May 18, 2010
Difference between random and imprinted X inactivation in common volesElena V Dementyeva, Alexander I Shevchenko, Olga V Anopriyenko, et al.
Plos One|May 19, 2012
A regulatory potential of the Xist gene promoter in vole M. rossiaemeridionalisKonstantin E Orishchenko, Sophia V Pavlova, Eugeny A Elisaphenko, et al.
Chromosoma|November 20, 2017
Impact of Xist RNA on chromatin modifications and transcriptional silencing maintenance at different stages of imprinted X chromosome inactivation in vole Microtus levisAlexander I Shevchenko, Elena V Grigor'eva, Sergey P Medvedev, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|January 21, 2009
X-chromosome upregulation and inactivation: two sides of the dosage compensation mechanism in mammalsElena V Dementyeva, Alexander I Shevchenko, Suren M Zakian
International Journal of Molecular Sciences|August 29, 2024
Studying Pathogenetic Contribution of a Variant of Unknown Significance, p.M659I (c.1977G > A) in MYH7, to the Development of Hypertrophic Cardiomyopathy Using CRISPR/Cas9-Engineered Isogenic Induced Pluripotent Stem CellsSophia V Pavlova, Angelina E Shulgina, Suren M Zakian, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|July 25, 2009
Mosaic heterochromatin of the inactive X chromosome in vole Microtus rossiaemeridionalisAlexander I Shevchenko, Sophia V Pavlova, Elena V Dementyeva, et al.
The International Journal of Developmental Biology|May 7, 2019
Diverse developmental strategies of X chromosome dosage compensation in eutherian mammalsAlexander I Shevchenko, Elena V Dementyeva, Irina S Zakharova, et al.
International Journal of Molecular Sciences|December 17, 2024
Generation of Isogenic iPSC Lines for Studying the Effect of the p.N515del (c.1543_1545delAAC) Variant on MYBPC3 Function and Hypertrophic Cardiomyopathy PathogenesisSophia V Pavlova, Angelina E Shulgina, Julia M Minina, et al.
Cardiology Research and Practice|April 26, 2016
Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease ModelingDaniel R Bayzigitov, Sergey P Medvedev, Elena V Dementyeva, et al.
Plos One|February 8, 2014
Dynamics of the two heterochromatin types during imprinted X chromosome inactivation in vole Microtus levisEvgeniya A Vaskova, Elena V Dementyeva, Alexander I Shevchenko, et al.
Chromosoma|May 18, 2010
Difference between random and imprinted X inactivation in common volesElena V Dementyeva, Alexander I Shevchenko, Olga V Anopriyenko, et al.
Plos One|May 19, 2012
A regulatory potential of the Xist gene promoter in vole M. rossiaemeridionalisKonstantin E Orishchenko, Sophia V Pavlova, Eugeny A Elisaphenko, et al.
Chromosoma|November 20, 2017
Impact of Xist RNA on chromatin modifications and transcriptional silencing maintenance at different stages of imprinted X chromosome inactivation in vole Microtus levisAlexander I Shevchenko, Elena V Grigor'eva, Sergey P Medvedev, et al.
Pageof 2